Amy Nicole Nayar, Pharm.D., M.S., serves as the Personalized Medicine Coalition’s President and CEO. A pioneering leader in the field, Dr. Nayar excels at creating patient-centered change by connecting and mobilizing stakeholders from industry, government, patient communities, and clinical settings. She advocates for integrated health care transformation, fostering collaborations, encouraging adaptive thinking, and championing solution-focused initiatives to set new benchmarks in patient care.
Prior to her time with the Coalition, Dr. Nayar served as Vice President for U.S. Patient Advocacy & Government Affairs at Novartis Gene Therapies. In this capacity, she collaborated to streamline genetic testing and treatment pathways, paving the way for patients to benefit from some of the world’s most innovative personalized treatments.
With a rich 25-year history in the global health care industry, including senior executive roles at Pfizer, AbbVie, and Porter Novelli, Dr. Nayar has consistently championed innovation in patient-centered care. As a clinician, health economist, and outcomes researcher with expertise in artificial intelligence, Dr. Nayar brings a rare blend of clinical insight and technological acumen to PMC.
